Loading...
XHKG1349
Market cap103mUSD
Dec 23, Last price  
2.47HKD
1D
-0.80%
1Q
32.80%
Jan 2017
-61.88%
Name

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XHKG:1349 chart
P/E
6.96
P/S
0.89
EPS
0.33
Div Yield, %
9.46%
Shrs. gr., 5y
2.30%
Rev. gr., 5y
2.82%
Revenues
851m
-17.50%
20,117,00019,764,00024,927,00031,990,00061,905,00092,390,000133,890,000232,527,000415,925,000470,900,000579,463,000621,870,000497,694,000740,422,0001,029,294,769833,802,6931,140,313,0881,031,159,838850,733,212
Net income
109m
-21.28%
-30,356,000-22,030,000-29,550,000-23,402,000-7,320,0003,681,00030,826,00053,159,00087,218,000118,258,000127,723,000138,708,00075,287,000150,982,000227,357,983164,662,782213,295,758137,997,098108,627,368
CFO
71m
-57.03%
-21,399,000-17,185,000-15,890,0007,724,000-7,108,00049,589,000110,188,00089,442,00088,359,00096,296,000140,574,00042,711,000173,939,000269,232,612113,003,294268,899,775165,268,62271,015,450
Dividend
Aug 26, 20240.0217 HKD/sh
Earnings
Jun 27, 2025

Profile

PFC Device Inc., together with its subsidiaries, engages in the research and development, design, manufacture, and sale of power discrete semiconductors under the PFC brand name in China, Hong Kong, Taiwan, and other Asian countries. It offers rectifiers, MOSFETs, IGBTs, bridge rectifiers, and packaging products for general power, consumer, industrial, and automotive applications. The company also provides power supply products; package products for mobile phone charger; and power supply applications for network and communication. In addition, it engages in investment and trade mark holding activities. The company was incorporated in 2016 and is headquartered in Chai Wan, Hong Kong. PFC Device Inc. is a subsidiary of Lotus Atlantic Limited.
URL
http://www.fd-zj.com
IPO date
Aug 13, 2002
Employees
138
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
850,733
-17.50%
1,031,160
-9.57%
1,140,313
36.76%
Cost of revenue
586,032
878,492
921,450
Unusual Expense (Income)
NOPBT
264,701
152,668
218,863
NOPBT Margin
31.11%
14.81%
19.19%
Operating Taxes
(10,922)
(4,979)
3,540
Tax Rate
1.62%
NOPAT
275,623
157,647
215,323
Net income
108,627
-21.28%
137,997
-35.30%
213,296
29.53%
Dividends
(76,152)
(71,039)
(52,150)
Dividend yield
2.89%
1.99%
1.30%
Proceeds from repurchase of equity
9,516
7,502
BB yield
-0.27%
-0.19%
Debt
Debt current
6,329
109,216
8,676
Long-term debt
28,234
39,414
53,852
Deferred revenue
2,153
34,043
40,798
Other long-term liabilities
34,043
40,798
Net debt
(1,448,866)
(1,447,044)
(1,474,217)
Cash flow
Cash from operating activities
71,015
165,269
268,900
CAPEX
(98,968)
(87,304)
(120,116)
Cash from investing activities
(45,377)
(96,748)
(355,671)
Cash from financing activities
(118,977)
11,608
(101,164)
FCF
232,742
53,865
157,800
Balance
Cash
1,195,896
1,289,303
1,208,881
Long term investments
287,533
306,371
327,864
Excess cash
1,440,893
1,544,116
1,479,729
Stockholders' equity
1,022,978
981,063
917,221
Invested Capital
1,355,019
1,455,207
1,355,509
ROIC
19.62%
11.22%
15.89%
ROCE
11.13%
6.36%
9.81%
EV
Common stock shares outstanding
1,034,170
1,031,233
1,044,766
Price
2.55
-26.51%
3.47
-9.87%
3.85
0.79%
Market cap
2,637,135
-26.30%
3,578,378
-11.04%
4,022,348
6.42%
EV
1,189,278
2,132,454
2,548,826
EBITDA
324,629
233,639
279,716
EV/EBITDA
3.66
9.13
9.11
Interest
3,066
1,538
1,055
Interest/NOPBT
1.16%
1.01%
0.48%